Target type: biologicalprocess
The formation of a covalent cross-link between or within protein chains. [GOC:jsg]
Peptide cross-linking is a chemical process that covalently links two or more peptides together. This process can occur naturally within cells or be induced artificially in the lab. The resulting cross-linked peptides can form stable complexes that are resistant to enzymatic degradation. This makes them valuable tools for studying protein interactions and structures.
The process of peptide cross-linking can be divided into several steps. First, a cross-linking reagent is introduced to the system. This reagent typically contains two reactive groups that can react with amino acid residues on the peptides. The cross-linking reagent can be specific for certain amino acid residues, or it can be more promiscuous and react with a variety of residues.
Once the cross-linking reagent has been introduced, it can react with the peptides to form a cross-linked complex. The resulting cross-linked complex will be stabilized by the covalent bond between the peptides.
There are many different cross-linking reagents available, and each reagent has its own unique properties. Some reagents are more efficient at cross-linking peptides than others. Some reagents are more specific for certain amino acid residues than others. And some reagents are more stable than others.
Peptide cross-linking is a powerful tool that can be used to study protein interactions and structures. It can be used to identify new protein-protein interactions, to map protein-protein interfaces, and to study the dynamics of protein complexes.
In addition to its use in research, peptide cross-linking is also used in the development of new drugs and therapies. For example, cross-linking reagents are used to develop new antibiotics that target bacterial proteins.
The process of peptide cross-linking can be summarized as follows:
1. A cross-linking reagent is introduced to the system.
2. The cross-linking reagent reacts with amino acid residues on the peptides to form a cross-linked complex.
3. The resulting cross-linked complex is stabilized by the covalent bond between the peptides.
Peptide cross-linking is a versatile and powerful tool that has a wide range of applications in biology, chemistry, and medicine.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein-glutamine gamma-glutamyltransferase 2 | A protein-glutamine gamma-glutamyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P21980] | Homo sapiens (human) |
Fibronectin | A fibronectin that is encoded in the genome of human. [PRO:DNx, UniProtKB:P02751] | Homo sapiens (human) |
Coagulation factor XIII A chain | A coagulation factor XIII A chain that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00488] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanone | ZM39923: structure in first source | naphthalenes | |
beta-lapachone | beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities. beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
vitamin k 3 | Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
5-bromoisatin | indoles | anticoronaviral agent | |
isatin | tribulin: endogenous MONOAMINE OXIDASE inhibitory activity extractable into ethyl acetate found in brain and many mammalian tissues and fluids; ISATIN is a major component; produced in excess following alcohol withdrawal; | indoledione | EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
indirubin | |||
5-Chloro-1H-indole-2,3-dione | indoles | anticoronaviral agent | |
5-iodoisatin | 5-iodoisatin: structure in first source | indoles | anticoronaviral agent |
isoindigotin | isoindigotin: used in treatment of chronic granulocytic leukemia; structure given in first source | ||
n-phenylacrylamide | N-phenylacrylamide: structure in first source | ||
nsc 95397 | 1,4-naphthoquinones | ||
s 1033 | (trifluoromethyl)benzenes; imidazoles; pyridines; pyrimidines; secondary amino compound; secondary carboxamide | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | |
ag-213 | tyrphostin 47: inhibits protein-tyrosine kinase activity of EGF-R both in vitro and in living cells; | ||
urb 597 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester: a fatty acid amide hydrolase inhibitor; structure in first source | biphenyls | |
rottlerin | rottlerin : A chromenol that is 2,2-dimethyl-2H-chromene substituted by hydroxy groups at positions 5 and 7, a 3-acetyl-2,4,6-trihydroxy-5-methylbenzyl group at position 6 and a (1E)-3-oxo-1-phenylprop-1-en-3-yl group at position 8. A potassium channel opener, it is isolated from Mallotus philippensis. rottlerin: an angiogenesis inhibitor; an inhibitor of protein kinase Cdelta (PKCdelta) and calmodulin kinase III; RN refers to (E)-isomer; do not confuse this chalcone with an anthraquinone that is also called rottlerin (RN 481-72-1); | aromatic ketone; benzenetriol; chromenol; enone; methyl ketone | anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite |
gw-5074 | |||
cay 10499 | carbamate ester | ||
glutaminase | |||
guanylyl imidodiphosphate | guanosine 5'-[beta,gamma-imido]triphosphate : A nucleoside triphosphate analogue that is GTP in which the oxygen atom bridging the beta- to the gamma- phosphate is replaced by a nitrogen atom A non-hydrolyzable analog of GTP, it binds tightly to G-protein in the presence of Mg(2+). Guanylyl Imidodiphosphate: A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of ADENYLYL CYCLASES. | nucleoside triphosphate analogue |